David Larsen
Stock Analyst at BTIG
(2.11)
# 2,642
Out of 4,829 analysts
73
Total ratings
33.93%
Success rate
-1.89%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Upgrades: Buy | $28 | $22.00 | +27.27% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $55.21 | -36.61% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $96.66 | +34.49% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $23.53 | +31.75% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $156.13 | +66.53% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $30.82 | +62.23% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $22.35 | -10.51% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $28.54 | +145.27% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $3.58 | +95.53% | 1 | Sep 17, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $241.44 | -0.60% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.45 | +384.43% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $8.55 | +63.74% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.45 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.46 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $61.04 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $9.31 | +383.35% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $4.52 | +364.60% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.97 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $25.06 | +39.66% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.35 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $7.15 | +1,228.67% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.21 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $148.62 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $687.52 | -76.73% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.40 | +514.04% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $70.47 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $64.81 | +31.15% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $7.15 | +221.68% | 1 | Nov 2, 2017 |
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $22.00
Upside: +27.27%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $55.21
Upside: -36.61%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $96.66
Upside: +34.49%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $23.53
Upside: +31.75%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $156.13
Upside: +66.53%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $30.82
Upside: +62.23%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $22.35
Upside: -10.51%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $28.54
Upside: +145.27%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.58
Upside: +95.53%
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $241.44
Upside: -0.60%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.45
Upside: +384.43%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $8.55
Upside: +63.74%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.45
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $27.46
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $61.04
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $9.31
Upside: +383.35%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $4.52
Upside: +364.60%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.97
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $25.06
Upside: +39.66%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.35
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $7.15
Upside: +1,228.67%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $7.21
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $148.62
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $687.52
Upside: -76.73%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.40
Upside: +514.04%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $70.47
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $64.81
Upside: +31.15%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $7.15
Upside: +221.68%